|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO):a randomised,open-label,multicentre,phase 3 trial显示文摘 | Baselga J Bradbury I Eidtmann H | | 0，，9816： | 1 |
| 2 | Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study显示文摘 | Eidtmann H de Boer R Bundred N et ai | 2010 | Ann Oncol2010，21，11： | 1 |
| 3 | Lapatinib with trastuzumab for HER2-positive early breast cancer(NeoALT- TO) :a randomised,open-label,muhicentre,phase 3 trial 显示文摘 | Baselga J Bradbury I Eidtmann H | 2012 | Lancet2012，379，9816： | 1 |
| 4 | Lapatinib with trastuzumab for HER2-positive early breast cancer(NeoALTTO):a randomised,open-label,multicentre,phase 3 trial显示文摘 | Baselga J Bradbury I Eidtmann H | 2012 | Lancet2012，379，9816： | 1 |
| 5 | Overexpression of p53 and prognosis in breast cancer显示文摘 | Friedrichs K Gluba S Eidtmann H et al | 1993 | Cancer1993，72，12： | 1 |
| 6 | Lapatinib with trastuzumab for HER2- positive early breast cancer (NeoALTTO): a randomised, open-label, muhicentre, phase 3 trial显示文摘 | BASELGA J BRADBURY I EIDTMANN H | 2012 | Lancet2012，379，9816： | 1 |
| 7 | Efficacy of zoledronic ac- id in postmenopausal women with early breast cancer receiving ad- juvant letrozole: 36-month results of the ZO-FAST Study显示文摘 | Eidtmann H de Boer R Bundred N | 2010 | Ann Oncol2010，21，11： | 1 |
| 8 | Overexpression of p53 and prognosis in breast cancer显示文摘 | Friedrichs K Gluba S Eidtmann H | 1993 | Cancer1993，72，12： | 1 |
| 9 | Overexpression of p53 and prognosis in breast cancer显示文摘 | FRIEDRICHS K GLUBA S EIDTMANN H | 1993 | Cancer1993，72，12： | 1 |
| 10 | Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer显示文摘 | von Minckwitz G Eidtmann H Rezai M | 2012 | N Engl J Med2012，366，4： | 1 |
| 11 | Efficacy of zohdmnie acid in postmenopausal women with early breast cancer receiving adjuvant letrozole:36-month results of the ZO- FAST Study 显示文摘 | Eidtmann H de Boer H Bundred N | 2010 | Ann Oneol2010，21，11： | 1 |
| 12 | Efficacy of zoledronicacid in postmenopausal women with early breast cancer receivingadjuvant letrozole ; 36-month results of the ZO-FAST Study 显示文摘 | Eidtmann H de Boer R Bundred N | 2010 | Ann Oncol2010，21，11： | 1 |
| 13 | Overexpression of P53and prognosis in breast-cancer显示文摘 | Friedrichs K Gluba S Eidtmann H | 1993 | Cancer1993，72，12： | 1 |
| 14 | Overexpression of p53 and prognosis in breast cancer显示文摘 | Friedrichs K Gluba S Eidtmann H | 1993 | Cancer1993，72，12： | 1 |
| 15 | Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer显示文摘 | Von Minckwitz G Eidtmann H Rezai M | 2012 | N Engld J Medi2012，366，4： | 1 |
| 16 | Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial显示文摘 | Michael Gnant Brigitte Mlineritsch Herbert Stoeger Gero Luschin-Ebengreuth Dietmar Heck Christian Menzel Raimund Jakesz Michael Seifert Michael Hubalek Gunda Pristauz Thomas Bauernhofer Holger Eidtmann Wolfgang Eiermann Guenther Steger Werner Kwasny Peter | 2011 | Lancet Oncology2011，，7： | 1 |
| 17 | Over expression of P53 and prognosis in breast cancer显示文摘 | FRIEDRICH S K GLUBA S EIDTMANN H | 1993 | Cancer1993，54，24： | 1 |
| 18 | Overexpression of P53 and prognosis in breast cancer显示文摘 | Friedrichs K Gluba S Eidtmann H | 1993 | Cancer1993，72，12： | 1 |
| 19 | Overexpression of p53 and prognosis in breast cancer显示文摘 | Gluba S Eidtmann H | 1993 | Cancer1993，72，12： | 1 |
| 20 | Overexpression of p53 and prognosis in breast cancer 显示文摘 | Friedrichs K Gluba S Eidtmann H | 1993 | Cancer1993，72，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员